Hongyu Wuzhou announced that the cumulative deviation value of the closing price increase of the company's stock reached 45.75% for 2 consecutive trading days, which was an abnormal fluctuation. After verification, the company has recently been operating normally. Other than the asset purchase plan disclosed on July 22, there are no matters that should be disclosed but have not been disclosed. The company warned that there is uncertainty about the approval time and price of this transaction, and it may also face risks such as integration and impairment of goodwill. As of July 23, there was a big difference between the company's price-earnings ratio and the industry, reminding investors to be aware of the risks.

Hongyu Wuzhou announced that the cumulative deviation value of the closing price increase of the company's stock reached 45.75% for 2 consecutive trading days, which was an abnormal fluctuation. After verification, the company has recently been operating normally. Other than the asset purchase plan disclosed on July 22, there are no matters that should be disclosed but have not been disclosed. The company warned that there is uncertainty about the approval time and price of this transaction, and it may also face risks such as integration and impairment of goodwill. As of July 23, there was a big difference between the company's price-earnings ratio and the industry, reminding investors to be aware of the risks.